Regarding a AUD 110,000,000 financing given to Parnell Pharmaceuticals Holdings Pty Ltd (“Parnell”), an affiliate of DW Healthcare Partners (“DWHP”), in connection with the purchase of Noble Pharma, LLC (“Noble Pharma”), Baker McKenzie has advised The Hong Kong and Shanghai Banking Corporation Limited as required lead arranger and bookrunner.